Trustmark National Bank Trust Department’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-405
Closed -$45K 632
2019
Q1
$45K Hold
405
﹤0.01% 357
2018
Q4
$37K Buy
+405
New +$41K ﹤0.01% 370
2018
Q2
Sell
-2,905
Closed -$241K 271
2018
Q1
$241K Hold
2,905
0.03% 240
2017
Q4
$265K Hold
2,905
0.03% 236
2017
Q3
$221K Sell
2,905
-90
-3% -$6.8K 0.03% 247
2017
Q2
$225K Buy
+2,995
New +$208K 0.03% 241
2016
Q3
Sell
-4,919
Closed -$206K 302
2016
Q2
$206K Buy
+4,919
New +$227K 0.03% 270

Other funds holding PRAH

Trustmark National Bank Trust Department's PRAH Position: Q2 2019 in Review

Trustmark National Bank Trust Department sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 405 shares — an estimated $45K sold.

Trustmark National Bank Trust Department first reported a position in PRAH in Q2 2016 and held it in 7 quarters. The position peaked at $265K in Q4 2017. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • Trustmark National Bank Trust Department reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 405 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $45K.
  • Trustmark National Bank Trust Department first reported a position in PRA Health Sciences, Inc. in Q2 2016 and held it in 7 quarters.
  • Trustmark National Bank Trust Department's PRA Health Sciences, Inc. position peaked at $265K in Q4 2017.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Trustmark National Bank Trust Department's 13F filing for Q2 2019, filed 13 Aug 2019.